These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35449318)

  • 1. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
    Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
    Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
    Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
    J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
    Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
    BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
    Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
    Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
    Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
    Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
    Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
    Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
    Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
    Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer.
    Ma T; Liang Y; Li Y; Song X; Zhang N; Li X; Chen B; Zhao W; Wang L; Yang Q
    Cell Signal; 2020 Apr; 68():109536. PubMed ID: 31927036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
    Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
    Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer.
    Xue X; Yang YA; Zhang A; Fong KW; Kim J; Song B; Li S; Zhao JC; Yu J
    Oncogene; 2016 May; 35(21):2746-55. PubMed ID: 26364613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.
    Chen K; Zhang Z; Yu A; Li J; Liu J; Zhang X
    Biomed Res Int; 2020; 2020():6575724. PubMed ID: 33195697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA DLGAP1-AS1 promotes cell proliferation in hepatocellular carcinoma via sequestering miR-486-5p.
    Peng X; Wei F; Hu X
    J Cell Biochem; 2020 Feb; 121(2):1953-1962. PubMed ID: 31633236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
    Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
    Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
    Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
    Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance.
    Liu Z; Liu J; Ebrahimi B; Pratap UP; He Y; Altwegg KA; Tang W; Li X; Lai Z; Chen Y; Shen L; Sareddy GR; Viswanadhapalli S; Tekmal RR; Rao MK; Vadlamudi RK
    Breast Cancer Res; 2022 Apr; 24(1):26. PubMed ID: 35395812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer.
    Jin X; Ge LP; Li DQ; Shao ZM; Di GH; Xu XE; Jiang YZ
    Mol Cancer; 2020 May; 19(1):87. PubMed ID: 32393270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DLGAP1-AS2 promotes the radioresistance of rectal cancer stem cells by upregulating CD151 expression via E2F1.
    Xiao SY; Yan ZG; Zhu XD; Qiu J; Lu YC; Zeng FR
    Transl Oncol; 2022 Apr; 18():101304. PubMed ID: 35144091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.